Biotech and Drug Stocks
7.46k followers • 31 symbols Watchlist by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies.
Curated by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies. These companies develop specialty drugs and treatments for various diseases and medical conditions. Although there are risks associated with the success of the drug, those that succeed tend to have a strong series of earnings growth over a period of time, especially when they are backed by patents.
The list includes stocks priced at $5 or more with a three month average daily trading volume in excess of 200,000 shares. This list is generated daily and sorted by market cap; the gains are based on the latest closing price and limited to the top 30 stocks that meet the criteria.
This watchlist is similar to a discontinued watchlist called Battling Cancer.
Background
Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the Global Financial Markets. We bring these insights to you in the form of watchlists.
Find other winning investment ideas with the Yahoo Finance Screener.
How are these weighted?The stocks in this watchlist are weighted equally.
Performance
| Watchlist | Change Today | 1 Month Return | 1 Year Return | Total Return |
|---|---|---|---|---|
| Biotech and Drug Stocks | - | - | - | - |
| ^GSPC | -0.27% | +4.66% | +28.02% | +5606.46% |
31 Symbols
| Symbol | Company Name | Last Price | Change | % Change | Market Time | Volume | Avg Vol (3 month) | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | 802.91 | -0.26 | -0.03% | 4:00 p.m. EDT | 1.75M | 2.75M | 763.09B |
| NVO | Novo Nordisk A/S | 134.03 | -1.13 | -0.84% | 4:00 p.m. EDT | 2.67M | 4.53M | 598.14B |
| JNJ | Johnson & Johnson | 153.5 | +2.26 | +1.49% | 4:00 p.m. EDT | 6.39M | 7.38M | 369.43B |
| MRK | Merck & Co., Inc. | 131.1 | +0.34 | +0.26% | 4:02 p.m. EDT | 4.26M | 8.22M | 332.05B |
| ABBV | AbbVie Inc. | 159.61 | -3.32 | -2.04% | 4:00 p.m. EDT | 6.89M | 5.63M | 281.85B |
| AZN | AstraZeneca PLC | 78.8 | -0.38 | -0.48% | 4:00 p.m. EDT | 3.56M | 5.33M | 244.32B |
| NVS | Novartis AG | 101.96 | -0.88 | -0.86% | 4:00 p.m. EDT | 1.04M | 1.55M | 208.58B |
| RHHBY | Roche Holding AG | 31.67 | -0.65 | -2.01% | 4:00 p.m. EDT | 4.70M | 2.93M | 205.62B |
| PFE | Pfizer Inc. | 29.6 | +1.04 | +3.64% | 4:00 p.m. EDT | 46.11M | 42.69M | 167.73B |
| AMGN | Amgen Inc. | 309.41 | -5.44 | -1.73% | 4:00 p.m. EDT | 2.84M | 2.74M | 165.98B |
| SNY | Sanofi | 50.36 | +1.41 | +2.88% | 4:00 p.m. EDT | 2.12M | 1.97M | 125.87B |
| VRTX | Vertex Pharmaceuticals Incorporated | 447.53 | +5.53 | +1.25% | 4:00 p.m. EDT | 1.08M | 1.03M | 115.49B |
| REGN | Regeneron Pharmaceuticals, Inc. | 983.8 | -10.15 | -1.02% | 4:00 p.m. EDT | 308.63k | 449.62k | 108.40B |
| GSK | GSK plc | 45.78 | +1.32 | +2.97% | 4:00 p.m. EDT | 6.10M | 3.17M | 93.35B |
| BMY | Bristol-Myers Squibb Company | 42.34 | +0.07 | +0.17% | 4:00 p.m. EDT | 16.52M | 15.55M | 85.83B |
| GILD | Gilead Sciences, Inc. | 67.8 | +0.51 | +0.76% | 4:00 p.m. EDT | 5.68M | 6.91M | 84.47B |
| ZTS | Zoetis Inc. | 172.05 | -0.74 | -0.43% | 4:00 p.m. EDT | 1.52M | 3.65M | 78.51B |
| MRNA | Moderna, Inc. | 163.33 | +19.64 | +13.67% | 4:00 p.m. EDT | 12.61M | 3.86M | 62.59B |
| TAK | Takeda Pharmaceutical Company Limited | 13.06 | -0.14 | -1.06% | 4:00 p.m. EDT | 1.03M | 1.56M | 41.19B |
| HLN | Haleon plc | 8.5 | -0.02 | -0.23% | 4:00 p.m. EDT | 6.03M | 7.04M | 38.81B |
| BIIB | Biogen Inc. | 225.21 | -2.48 | -1.09% | 4:00 p.m. EDT | 1.22M | 1.23M | 32.79B |
| BAYRY | Bayer Aktiengesellschaft | 7.72 | -0.04 | -0.52% | 4:00 p.m. EDT | 1.67M | 2.10M | 30.34B |
| BNTX | BioNTech SE | 102.3 | +10.23 | +11.11% | 4:00 p.m. EDT | 3.60M | 646.78k | 24.65B |
| ARGX | argenx SE | 363.73 | +7.07 | +1.98% | 4:00 p.m. EDT | 556.53k | 272.47k | 21.62B |
| GMAB | Genmab A/S | 29.81 | +0.66 | +2.26% | 4:00 p.m. EDT | 380.47k | 519.80k | 19.30B |
| TEVA | Teva Pharmaceutical Industries Limited | 16.88 | +0.29 | +1.75% | 4:00 p.m. EDT | 11.26M | 10.13M | 19.26B |
| ALNY | Alnylam Pharmaceuticals, Inc. | 150.9 | +1.28 | +0.86% | 4:00 p.m. EDT | 339.03k | 577.23k | 19.09B |
| BGNE | BeiGene, Ltd. | 167.92 | +0.53 | +0.32% | 4:00 p.m. EDT | 99.95k | 210.72k | 19.05B |
| ALPMY | Astellas Pharma Inc. | 9.71 | +0.12 | +1.25% | 3:59 p.m. EDT | 221.09k | 326.96k | 17.46B |
| RPRX | Royalty Pharma plc | 27.33 | +0.16 | +0.59% | 4:00 p.m. EDT | 2.40M | 2.61M | 16.33B |
GuruFocus.comInsider Sale: CEO & President Reshma Kewalramani Sells 15,202 Shares of Vertex ...
On May 20, 2024, Reshma Kewalramani, CEO & President of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), executed a sale of 15,202 shares of the company, according to the SEC Filing.
BloombergSecond US Human Bird Flu Infection Reported in Michigan
(Bloomberg) -- A Michigan farmworker tested positive with bird flu, the second person to contract the potentially lethal virus that has run rampant in US cattle.Most Read from BloombergThese Flight Routes Suffer the World’s Worst TurbulenceNvidia Delivers on AI Hopes, Igniting $140 Billion Stock RallyCiti Trader Got 711 Warning Messages Before Sparking Flash CrashTech Up in Late Hours as Nvidia Emboldens AI Bulls: Markets WrapThe farmworker experienced mild symptoms in the eye after contact with
Barrons.comModerna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Last year, Moderna began early-stage tests of a number of avian flu vaccines that target different strains of the virus.
